Status:
UNKNOWN
Acupuncture and Chinese Herbal Medicine to Improve Live Birth Rate of in Vitro Fertilization (IVFAct)
Lead Sponsor:
Heilongjiang University of Chinese Medicine
Conditions:
In Vitro Fertilization
Eligibility:
FEMALE
20-40 years
Phase:
NA
Brief Summary
The most successful treatment for infertility is in vitro fertilization (IVF), but less than 10% of infertile couples undergo IVF because of the high cost and relatively low success rate. Many patient...
Detailed Description
The objective of this multi-centre double blind randomized trial is to evaluate the efficacy of acupuncture with or without CHM on the live birth of IVF. The randomization process will be coordinated ...
Eligibility Criteria
Inclusion
- Women ≥20 to ≤40 years of age
- Indications for IVF
- Duration of infertility \>1 year
- Undergoing IVF with an intention of fresh ET on day 3 or 5.
Exclusion
- Women with an intention to replace frozen embryos only.
- Preimplantation genetic testing
- History of recurrent miscarriages defined as having three consecutive miscarriages.
- Having acupuncture or CHM for infertility within 3 months prior the IVF
- Women with abnormal liver or renal function tests
Key Trial Info
Start Date :
November 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
2728 Patients enrolled
Trial Details
Trial ID
NCT04407871
Start Date
November 1 2021
End Date
December 31 2022
Last Update
September 23 2021
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
2
The First Hospital of Lanzhou University
Lanzhou, Gansu, China
3
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
4
Tongji Hospital, Tongji Medical College Huazhong University of Science & Technology
Wuhan, Hubei, China